Company profilePharmaceutical#151 of 1,318 in Pakistan✓ No DRAP alerts

JAENS PHARMACEUTICAL INDUSTRIES PVT LTD

Pharmaceutical company · 114 brands · 103 molecules

Ranked #3 of 32 companies in Antiinflammatory Agents And Antiinfectives In Combination

114 registered products 44 pharmaceutical brands 103 distinct molecules 0 DRAP alerts

Company overview

114
registered products
44
pharmaceutical brands
103
distinct molecules
12
therapeutic classes
0
DRAP alerts

JAENS PHARMACEUTICAL INDUSTRIES PVT LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 114 product registrations across 103 distinct molecules. It is the 151st largest registrant in Pakistan by product count, and ranks 3rd of 32 in Antiinflammatory Agents And Antiinfectives In Combination. Its portfolio is concentrated in Antiinflammatory Agents And Antiinfectives In Combination and Anti-Infective, Ophthalmologicals. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by JAENS

55 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Macrolides, Lincosamides And Streptogramins 2
Mydriatics And Cycloplegics 1
Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

54
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20259
202645

Top molecules by brand count

Eye21 brands
Atorvastatin4 brands
Timolol3 brands
Prednisolone3 brands

Therapeutic classes

Antiinflammatory Agents And Antiinfectives In Combination · 8Anti-Infective, Ophthalmologicals · 8Antiinflammatory Agents, Corticosteroids · 3Decongestants And Antiallergics · 3Antiglaucoma Preparations And Miotics · 2Antianemic, Iron Preparations · 2Mydriatics And Cycloplegics · 2Other Ophthalmologicals, Lubricant · 1Nasal Preparations · 1Otologicals · 1Vitamin B12 Plain · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official81 products · Rs 4.1 – Rs 4,521.02
Median across source: Rs 300.14

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Atco Pharma International (Pvt) Ltd holds 206 molecules not in this portfolio
Acetylsalicylic AcidAdapaleneAdapleneAlbuterolAminophyllineAmlodipine
Sante (Private) Limited holds 62 molecules not in this portfolio
AmlodipineAzithromycin Azithromycin DihydarteBenzoyl PeroxideBetamethasoneChloroquineClindamycin
Barrett Hodgson Pakistan (Private) Ltd. holds 143 molecules not in this portfolio
Acetylsalicylic AcidAmlodipineAspirinBacitracinBacitracin AndlignocaineBambuterol

Get the full profile for JAENS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.